Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motor Unit Abnormalities After Capsaicin-Induced Sensitization
NCT04361149Phase 4Completed
- Sponsor
- Toronto Rehabilitation Institute
- Start
- Oct 2019
- Primary completion
- Dec 2019
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Capsaicin Topical with Placebo Topical (2 arms). Primary endpoint: Pain and Presence of Central Sensitization at 3 weeks. Started Oct 2019; status: completed.
02
Drugs
capsaicin 8% patch
Beyond the preview
Go deeper on NCT04361149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361149.